The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines ... The current presentation of the vaccine consists of a lyophilised (powder) antigen and a liquid adjuvant, which healthcare ...